reteral stenting in orthotopic bladder substitutes
Not Applicable
Recruiting
- Conditions
- CancerSurgeryUrological and Genital Diseasesbladder cancer
- Registration Number
- PACTR201301000446118
- Lead Sponsor
- Mansoura Urology and Nephrology Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Orthotopic substitution
negative ureteral safety margin
Exclusion Criteria
incontinent urinary diversion
Short ureters
Technical difficulties
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of ureteral stenting in orthotopic bladder substitutes for bladder cancer patients?
How does perioperative external ureteral catheter stenting compare to internal double J stents in urological surgery outcomes for bladder cancer?
What biomarkers are used to predict the effectiveness of ureteral stenting in orthotopic bladder substitutes post-surgery?
What are the potential adverse events associated with internal double J stents in orthotopic bladder substitutes and their management strategies?
Are there any combination approaches or alternative therapies being explored alongside ureteral stenting for bladder cancer treatment in urological research?